Clinical Trials Logo

Actively Extending Plaque Psoriasis clinical trials

View clinical trials related to Actively Extending Plaque Psoriasis.

Filter by:
  • None
  • Page 1

NCT ID: NCT01622348 Completed - Clinical trials for Moderate to Severe Plaque Psoriasis

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Start date: May 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate different dose levels of IMO-3100 compared to placebo administered for 4 weeks to patients with moderate to severe plaque psoriasis.